Close Window

Digital Look Email A Friend

Gilead Sciences to buy Immunomedics in $21bn deal

Published by Michele Maatouk on 14th September 2020

(Sharecast News) - Gilead Sciences has agreed to buy biotech company Immunomedics in a $21bn deal.

URL: http://www.digitallook.com/dl/news/story/31169609/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.